google-site-verification: googlec7193c3de77668c9.html

Breakthrough £90,000 Alzheimer's drugs unlikely to benefit patients, report suggests


A major review has provoked a backlash after concluding the medicines provide too little benefit to be noticed.


BBC News

Advertisements
Views: 3

See also  Want a tall, smart child? How IVF tests are selling a dream

Check Also

Study examines factors that influenced changes in US sterilization policy

[ Credit: Unsplash/CC0 Public Domain For decades, female sterilization has been one of the most …

Find it, treat it: 30-second test could help prevent stroke in Indigenous Australians

[ Aboriginal and Torres Strait Islander people should be screened for a common heart rhythm …

FDA approves Inqovi for acute myeloid leukemia

[ The U.S. Food and Drug Administration has approved Taiho Oncology’s Inqovi (decitabine and cedazuridine) …

Leave a Reply

Available for Amazon Prime
Start growing your traffic with our automated ad infrastructure.